BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 7455503)

  • 1. Serum enzymatic changes in patients with schistosomiasis treated with oxamniquine or hycanthone. Comparative study.
    Saéz-Alquézar A; Ohtsuki N; Sette Júnior H; Magnanelli AC; Raia S; da Silva LC
    Rev Inst Med Trop Sao Paulo; 1980; 22(1 Suppl 4):105-10, 225-31. PubMed ID: 7455503
    [No Abstract]   [Full Text] [Related]  

  • 2. [Resistance to hycanthone and oxamniquine in patients with a clinical hepato-intestinal form of schistosomiasis].
    Guimarães RX; Tchakerian A; Dias LC; de Almeida FM; Vilela MP; Cabeca M; Takeda AK
    AMB Rev Assoc Med Bras; 1979 Feb; 25(2):48-50. PubMed ID: 314642
    [No Abstract]   [Full Text] [Related]  

  • 3. Evaluation of oral therapy of mansonial schistosomiasis in the Sudan using single and multiple doses of hycanthone and oxamniquine drugs.
    Magzoub M; Adam SE
    J Pharmacol Exp Ther; 1978 Aug; 206(2):382-7. PubMed ID: 682120
    [No Abstract]   [Full Text] [Related]  

  • 4. The treatment of schistosomiasis mansoni in Murang'a District, Kenya: a double blind controlled trial of three hycanthone regimens and oxamniquine.
    Rees PH; Bowry HN; Roberts JM; Thuku JJ
    Am J Trop Med Hyg; 1975 Sep; 24(5):823-6. PubMed ID: 1190368
    [No Abstract]   [Full Text] [Related]  

  • 5. Use of praziquantel in patients with schistosomiasis mansoni previously treated with oxamniquine and/or hycanthone: resistance of Schistosoma mansoni to schistosomicidal agents.
    de Souza Dias LC; de Jesus Pedro R; Deberaldini ER
    Trans R Soc Trop Med Hyg; 1982; 76(5):652-9. PubMed ID: 7179419
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Drug therapy of mansoni schistosomiasis].
    Zeitune JM; Ramos SR; Sugmyama LC; Côrte AA
    Arq Gastroenterol; 1980; 17(2):88-95. PubMed ID: 7213141
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Experimental chemotherapy of Schistosoma curassoni in mice.
    Vercruysse J; Southgate VR; Rollinson D; Hilderson H
    Parasitol Res; 1989; 75(7):559-62. PubMed ID: 2771923
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of chemotherapy on experimental pulmonary schistosomiasis.
    de Almeida MA; Andrade ZA
    Am J Trop Med Hyg; 1983 Sep; 32(5):1049-54. PubMed ID: 6625060
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Curative chemotherapy and resistance to reinfection in murine schistosomiasis.
    Andrade ZA; Azevedo de Brito P
    Am J Trop Med Hyg; 1982 Jan; 31(1):116-21. PubMed ID: 7058973
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fatal hepatic necrosis in association with hycanthone.
    Hatchuel W
    S Afr Med J; 1978 Nov; 54(20):808. PubMed ID: 741319
    [No Abstract]   [Full Text] [Related]  

  • 11. Observations on the treatment of mansoni schistosomiasis with oxamniquine.
    Pedro RD; Dias LC; Amato Neto V; De Carvalho SA
    Rev Bras Pesqui Med Biol; 1979 Jun; 12(2-3):207-11. PubMed ID: 515473
    [No Abstract]   [Full Text] [Related]  

  • 12. Observations of the treatment of mansoni schistosomiasis with oxamniquine: efficacy in children and in persistent salmonellosis; resistance of a strain of Schistosoma mansoni; hepatic toxicity and neurological side effects.
    Pedro Rde J; de Souza Dias LC; Amato Neto V; de Carvalho SA
    Rev Inst Med Trop Sao Paulo; 1980; 22(1 Suppl 4):32-6, 148-52. PubMed ID: 7455507
    [No Abstract]   [Full Text] [Related]  

  • 13. Control of Schistosoma mansoni transmission by chemotherapy in St. Lucia. I. Results in man.
    Cook JA; Jordan P; Bartholomew RK
    Am J Trop Med Hyg; 1977 Sep; 26(5 Pt 1):887-93. PubMed ID: 907051
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term hepatocellular effects of hycanthone and of two other anti-Schistosomal drugs in mice infected with Schistosoma mansoni.
    Haese WH; Bueding E
    J Pharmacol Exp Ther; 1976 Jun; 197(3):703-13. PubMed ID: 180276
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Schistosoma mansoni-induced mesangiocapillary glomerulonephritis: influence of therapy.
    Martinelli R; Noblat AC; Brito E; Rocha H
    Kidney Int; 1989 May; 35(5):1227-33. PubMed ID: 2504987
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Electrocardiographic changes in patients with schistosomiasis mansoni treated with hycanthone].
    Takaoka L; Baldy JL; Passos JD; Soares EC; Zeitune JM; Siqueira JE
    Rev Inst Med Trop Sao Paulo; 1976; 18(5):378-86. PubMed ID: 1006067
    [No Abstract]   [Full Text] [Related]  

  • 17. Double-blind clinical trial comparing praziquantel with oxamniquine in the treatment of patients with schistosomiasis mansoni.
    Branchini ML; Pedro Rde J; Dias LC; Deberaldini ER
    Rev Inst Med Trop Sao Paulo; 1982; 24(5):315-21. PubMed ID: 6762635
    [No Abstract]   [Full Text] [Related]  

  • 18. Serum levels and efficacy of oxamniquine in patients with Schistosomiasis mansoni following administration of a therapeutic dose.
    da Silva LC; Sette Júnior H; Christo C; Sette PC; Kaye B
    Rev Inst Med Trop Sao Paulo; 1980; 22(1 Suppl 4):58-64, 175-81. PubMed ID: 7455511
    [No Abstract]   [Full Text] [Related]  

  • 19. Acute and early chronic phases of schistosomiasis mansoni in children treated with hycanthone.
    Tonelli E; Penna FJ; Leão E; Miranda D
    Acta Gastroenterol Latinoam; 1975 Jul; 6(3):125-36. PubMed ID: 1179940
    [No Abstract]   [Full Text] [Related]  

  • 20. [Therapeutic evaluation of oxamniquine in schistosomiasis mansoni].
    de Almeida FM; Vilela MP; Pricoli TI; Salem N; Guimarães RX; Ferraz CN; Arroyo JB; Fukuda Y; Cabeca M; Geocze S; Tancredi Neto A
    AMB Rev Assoc Med Bras; 1979 Mar; 25(3):101-4. PubMed ID: 315583
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.